| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
0.5 － ? |
Oritavancin (LY333328)  |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
1 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
1 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
4 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
8 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
16 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
16 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococci (CN19 + coagulase-negative + methicillin-resistant) |
- |
- |
0.5 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.06 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.25 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.25 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 － ? |
Oritavancin (LY333328) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (CN20 + coagulase-negative + methicillin-susceptible) |
- |
- |
4 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.125 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococci (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.25 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |